Evidence map›Paper›PMID 40119101›Full record

ArticleMedical oncology (Northwood, London, England)2025

Retraction Note: Niosomes: a novel targeted drug delivery system for cancer.

Maryam Moghtaderi, Kamand Sedaghatnia, Mahsa Bourbour, Mahdi Fatemizadeh, Zahra Salehi Moghaddam, Faranak Hejabi, Fatemeh Heidari, Sameer Quazi, Bahareh Farasati Far

Abstract readRetraction Notice
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Maryam MoghtaderiDepartment of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran.
Kamand SedaghatniaDepartment of Applied Chemistry, Azad University of Tehran South Branch, Tehran, Iran.
Mahsa BourbourDepartment of Biotechnology, Alzahra University, Tehran, Iran.
Mahdi FatemizadehDepartment of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Zahra Salehi MoghaddamDepartment of Microbial Biotechnology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
Faranak HejabiDepartment of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
Fatemeh HeidariDepartment of Cellular and Molecular Biology, Islamic Azad University, Tehran Medical Branch, Tehran, Iran.
Sameer QuaziGenLab Biosolutions Private Limited, Bangalore, Karnataka, India. colonel.quazi@gmail.com.ORCID http://orcid.org/0000-0002-1258-4088
Bahareh Farasati FarDepartment of Chemistry, Iran University of Science and Technology, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40119101

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.